GINA ROMMEL: Open Payments
NPI 1386018547 · WEST ISLIP, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 13 payments from 9 companies in 2025. Trend: 2023 $408 · 2024 $777 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $152 |
| AstraZeneca Pharmaceuticals LP | 2 | $55 |
| Tempus AI, Inc | 1 | $28 |
| Corcept Therapeutics | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| COLOPLAST CORP | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: JEMPERLI, XT CDX, Korlym, Lenvima, MYRISK, ELAHERE, Fabhalta.
Industry payments across NY — which companies pay providers there.
